Amgen earnings were $9.4B for the trailing 12 months ending Sep 30, 2026, with 33.4% growth year over year. The latest AMGN earnings report on Sep 30, 2026 announced Q3 2026 earnings of $3.9B, up 62.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AMGN reported annual earnings of $7.7B, with 88.5% growth.
AMGN past earnings growth
How has AMGN's earnings growth performed historically?
On AMGN's earnings call on Nov 3, 2026, Amgen (NASDAQ: AMGN) reported Q3 2026 earnings per share (EPS) of $7.14, up 19.4% year over year. Total AMGN earnings for the quarter were $3.86 billion. In the same quarter last year, Amgen's earnings per share (EPS) was $5.98.
As of the last Amgen earnings report, Amgen is currently profitable. Amgen's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $9.39 billion, a 34.06% increase year over year.
What was AMGN's earnings growth in the past year?
As of Amgen's earnings date in Nov 3, 2026, Amgen's earnings has grown 33.38% year over year. This is 6.46 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.85%. AMGN earnings in the past year totalled $9.39 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.